| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8623849 | Seminars in Arthritis and Rheumatism | 2017 | 45 Pages |
Abstract
To date, studies addressing prognostic factors are hypothesis generating and cannot be used to make any specific recommendations for routine clinical practice. A number of potential predictors/prognostic factors were identified, which require to be validated as being specific for response to RTX therapy and to enable more personalised use of this agent.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Carmelo Pirone, Claudia Mendoza-Pinto, Daniëlle A. van der Windt, Ben Parker, Miriam O׳Sullivan, Ian N. Bruce,